🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...
Status
Active Not Recruiting
Location
Stanford University School of Med /ID# 242809
Start Date
2022-05-17
Trial ID
NCT05308654
Treatments Being Tested
The purpose of this study is to learn about how well the drug daratumumab/h...
Status
Enrolling By Invitation
Location
Mayo Clinic Rochester
Start Date
2022-03-31
Trial ID
NCT05300451
Treatments Being Tested
The purpose of this research is to study the safety and efficacy of daratum...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2021-04-20
Trial ID
NCT04868838
Treatments Being Tested
iFIT is a trial for newly diagnosed transplant-ineligible patients with the...
Status
Recruiting
Location
Bristol Haematology and Oncology Centre
Start Date
2026-07
Trial ID
NCT07649525
Treatments Being Tested
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer i...
Status
Recruiting
Location
Mayo Clinic Hospital Scottsdale /ID# 278349
Start Date
2026-01-08
Trial ID
NCT07095452
Treatments Being Tested
This multicenter, prospective, single-arm exploratory study evaluates the e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-15
Trial ID
NCT07718308
Treatments Being Tested
This is a multicenter, open-label phase II study with 2 parallel cohorts fo...
Status
Recruiting
Location
IT-Ascoli Piceno-Ospedale Mazzoni [01-016]
Start Date
2025-12-12
Trial ID
NCT07107529
Treatments Being Tested
This is a multicenter, randomized, controlled, open-label, phase III clinic...
Status
Recruiting
Location
Beijing Chao-Yang Hospital, Capital Medical University
Start Date
2024-03-27
Trial ID
NCT06464991
Treatments Being Tested
The purpose of this pre-approval access (PAA) program is to provide treatme...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04264884
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and prel...
Status
Completed
Location
Princess Alexandra Hospital Woolloongabba
Start Date
2023-12-12
Trial ID
NCT06055075
Treatments Being Tested